Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: littlebitmoore2 who wrote (2518)	6/16/2009 4:07:24 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

TPI is still going down on an intra-day basis. It reported yesterday its 3rdQ results, and although revenue Increased 7.4% to $9.9M and earnings 48.8% to $1.9M, there is always the tendency of people to "sell after the news". <g> For the 9 months, the revenues and earnings are also better than in 2008 and the CF increased 150.6% to $4.4M They also reported 10 new approvals from the SFDA during the 9Ms. It also expects a new Production Facility to start functioning this Summer, which will increase the capacity for solid drugs by 300%. However, the stock today broke its initial near term support at the $2.85 level, (the next and more important support is at $2.65) As I am writing this note, the stock tried to rally to the $2.85 level, but has been brought down again. <g> Of course, the thing to watch now is to see if attempted rallies are or not successful. (See my comments about APWR on the last paragraph pf my note another thread.) Message 25719782 Bernard